Nett Philipp C
Bariatrische und metabolische Chirurgie, Universitäre Klinik für viszerale Chirurgie und Medizin, Inselspital, Bern, Switzerland.
Ther Umsch. 2013 Feb;70(2):119-22. doi: 10.1024/0040-5930/a000376.
The prevalence of obesity and its comorbidities is constantly rising and is one of the most threatening global health and economic problems worldwide. Whereas bariatric surgery is well accepted in the treatment of morbid obesity, surgical treatment for ist comorbidities (metabolic surgery) such as type 2 diabetes mellitus, dyslipidemia and other diseases are still under discussion. A more profound knowledge of its physiologic mechanisms is crucial for the future implementation of the bariatric and metabolic surgery to treat obesity-related comorbidities.
肥胖及其合并症的患病率在持续上升，是全球最具威胁性的健康和经济问题之一。尽管减重手术在治疗病态肥胖方面已被广泛接受，但针对其合并症（代谢手术）如2型糖尿病、血脂异常和其他疾病的手术治疗仍在讨论中。更深入了解其生理机制对于未来实施减重和代谢手术以治疗肥胖相关合并症至关重要。
